CJC-1295 with DAC: Identity, Albumin Binding, and Evidence Attribution
Explore the albumin-binding CJC-1295 literature, what early GH and IGF-I studies measured, and why catalog names do not establish trial equivalence.
24
Sep
17
Sep
GW-501516 (Cardarine): PPAR-delta Mechanisms and the 2026 Evidence
Evidence-scoped 2026 review of GW-501516 cardarine research: PPAR-delta mechanisms, 2024-2026 study timeline, doping-ban history, and open questions.
10
Sep
Epithalon Telomerase Research: Replication, Limits, and Open Questions
Review Epithalon telomerase research, the corrected 2025 cell study, older epithalamin human data, regulatory context, and the evidence still missing.
06
Sep
GHK-Cu Evidence in 2026: What 64 Records Actually Show
A critical map of GHK-Cu evidence in 2026: the new 64-record review, microneedle delivery study, recruiting CuHeal trial, and major research gaps.
03
Sep
Tesamorelin Visceral Fat Research: What the 2026 Meta-Analysis Shows
A 2026 meta-analysis pooled five tesamorelin trials in adults with HIV. Review visceral and liver fat findings, glucose data, and evidence limits.